Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 3, 2017

Primary Completion Date

December 21, 2020

Study Completion Date

December 21, 2020

Conditions
Breast NeoplasmPhysical Activity
Interventions
BEHAVIORAL

Exercise

"All participants randomized to the intervention group will be asked to keep an exercise log with the date, time, average heart rate obtained from a heart rate monitor, duration of workout and stretching, and any comments regarding the workout. Participants will be instructed to bring workout logs to infusion sessions for review. Participants will also wear a Polar Heart Rate monitor (US model RS400, Polar Electro Inc., Lake Success, NY) during exercise to monitor exercise intensity.~The aerobic exercise intervention will work toward the target of 75 minutes physical activity per week at 60%-85% of baseline VO2max."

Trial Locations (2)

17033

Penn State Hershey Medical Center, Hershey

19104

University of Pennsylvania, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NRG Oncology

OTHER

lead

Milton S. Hershey Medical Center

OTHER

NCT03280836 - Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | Biotech Hunter | Biotech Hunter